10 likes | 80 Views
This study explores ERα and PR mRNA levels in Oviducts, Uterus, and Cervix, assesses IGF-I and Thioredoxin mRNA expression in relation to varying conditions. Findings highlight potential molecular insights in reproductive health.
E N D
Oviducts Uterus Cervix A B C 25 a 20 ER mRNA (amol/g DNA) b 15 b ab a b a 10 a ab b ab b 5 D E F 0 12 a 10 8 PR mRNA (amol/g DNA) a a 6 ab ab b b b b b 4 b b 2 2.0 G H I 0 a a 1.5 IGF-I mRNA (amol/g DNA) 1.0 b a ab b ab 0.5 b 0 2.0 J K L b ab OVF OVF OVF a OVL OVL OVL OVXa OVXa OVXa OVXy OVXy OVXy 1.5 ac a Thioredoxin mRNA (amol/g DNA) c 1.0 b b ab b b b 0.5 0